Loading company…
ZETRONE combines low-temperature plasma, synthetic biology, and AI to convert gases and other feedstocks into biochemical products.
Founded in 2025 and based in Hwaseong-si, South Korea, ZETRONE develops biochemical processes using plasma, synthetic biology, and AI. Its work targets feedstocks such as atmospheric carbon dioxide, industrial by-product gases, waste cooking oil, and biomass. In October 2025, it raised an undisclosed amount of Seed funding from Bluepoint Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in